Mont-Saint-Guibert, Belgium – Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that Filippo Petti, Chief Executive Officer, will participate in a fireside chat at the virtual Jefferies Cell Therapy Summit on Monday, October 5, 2020, at 11:00 a.m. EDT.
The live virtual event will be available for investors to listen to via a webcast made available on the Celyad Oncology website. An archived replay of the event will be available on the Company’s website for approximately 30 days.
